It has been described an event of loss of heterozygosity at the 16.1q chromosome band in most human prostate cancers, where E-cadherin is located [53], which is associated with tumor grade, advanced clinical stage and poor survival [54]. This evidence concerns the gene CDH1 and prostate cancer.